As an industry leader in lipid delivery technology, Scindy Pharmaceutical leverages its deep understanding of lipid chemistry and proprietary advanced lipid material platform to achieve breakthrough applications of LNP technology. We proudly introduce the NeoLNP™ series of innovative cell transfection products, marking a new era of precise and efficient RNA delivery.

The NeoLNP™ Primary Immune Cell RNA Transfection Kit (SDR2008) is a game-changer for primary immune cell transfection. Addressing the industry challenges of low transfection efficiency and high cell damage in primary immune cells, SDR2008 achieves efficient RNA delivery in hard-to-transfect cells through dynamic membrane fusion technology. Equipped with novel pH-responsive ionizable lipids, it precisely releases payloads based on the cellular microenvironment, making it ideal for CAR-T cell therapy and dendritic cell vaccine research.

NeoLNP™ SDR2008: A Technological Breakthrough for Primary Immune Cell Transfection

Designed for Immunology Research: SDR2008 utilizes LNP non-viral vector technology to provide efficient RNA delivery for primary T cells and dendritic cells. Its simple operation and non-viral nature ensure high safety, suitable for preclinical and basic research. In human primary T cells, SDR2008 demonstrates superior transfection efficiency, with visible expression within 24 hours.

Human Primary T Cell Transfection: Using a 24-well plate, transfect with 1µg eGFP mRNA per well, followed by fluorescence microscopy and flow cytometry analysis after 24 hours.

NeoLNP™ One-Step RNA-LNP Encapsulation Solution

The NeoLNP™ Transfection Kit offers an innovative RNA-LNP encapsulation solution. Compared to traditional methods, NeoLNP™ requires no complex equipment, achieving zero-loss RNA encapsulation through a simple one-step mixing process, significantly reducing preparation time (1 minute vs. 10 hours). This technology overcomes the technical barriers of traditional LNP preparation, delivering optimized, standardized LNP formulations to researchers, providing a new experience for RNA transfection.